| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |